Evolent Health, Inc. Accounts Receivable, after Allowance for Credit Loss
Financial Statements › Balance Sheet › Assets
us-gaap:AccountsReceivableNet · last filed 2026-08-06
- 2026-06-30: Accounts Receivable, after Allowance for Credit Loss $450.49M.
- 2026-03-31: Accounts Receivable, after Allowance for Credit Loss $315.05M.
- 2025-12-31: Accounts Receivable, after Allowance for Credit Loss $310.99M.
- 2025-09-30: Accounts Receivable, after Allowance for Credit Loss $408.05M.
| Period end | Accounts Receivable, after Allowance for Credit Loss | Accounts Receivable, after Allowance for Credit Loss as first filed |
|---|---|---|
| 2026-06-30 | $450.49M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $315.05M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $310.99M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $408.05M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $359.82M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $440.75M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $420.91M 10-K · filed 2026-02-25 | |
| 2024-09-30 | $410.57M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $375.84M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $430.00M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $472.35B 10-K · filed 2025-02-21 | $472.40M 10-K · filed 2024-02-23 |
| 2023-09-30 | $424.10M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $366.20M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $284.70M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $269.10M 10-K · filed 2024-02-23 | |
| 2022-09-30 | $201.50M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $127.70M 10-Q · filed 2022-08-03 | |
| 2022-03-31 | $194.80M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $171.50M 10-K · filed 2023-02-24 | |
| 2021-09-30 | $195.00M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $264.10M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $211.00M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $173.70M 10-K · filed 2022-02-24 | |
| 2020-09-30 | $137.60M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $104.40M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $117.90M 10-Q · filed 2020-05-28 | |
| 2018-06-30 | $69.06M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $63.97M 10-Q · filed 2018-05-10 | |
| 2018-01-01 | $47.13M 10-Q · filed 2018-08-09 |